ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 135 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is 3.64 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,816 | -31.5% | 33,877 | -27.3% | 0.00% | – |
Q2 2023 | $74,140 | +11.6% | 46,629 | -49.7% | 0.00% | – |
Q1 2023 | $66,462 | +65.8% | 92,643 | +34.0% | 0.00% | – |
Q4 2022 | $40,078 | +208.3% | 69,160 | +400.3% | 0.00% | – |
Q3 2022 | $13,000 | -94.4% | 13,823 | -89.5% | 0.00% | – |
Q4 2021 | $231,000 | -47.4% | 131,155 | -35.1% | 0.00% | – |
Q3 2021 | $439,000 | -79.2% | 202,240 | -66.5% | 0.00% | -100.0% |
Q2 2021 | $2,115,000 | +409.6% | 604,300 | +1336.7% | 0.00% | – |
Q1 2021 | $415,000 | -56.4% | 42,062 | -52.1% | 0.00% | – |
Q4 2020 | $952,000 | -11.8% | 87,777 | -16.2% | 0.00% | – |
Q3 2020 | $1,079,000 | -70.5% | 104,807 | -40.1% | 0.00% | -100.0% |
Q2 2020 | $3,652,000 | +2256.1% | 174,871 | +1004.2% | 0.00% | – |
Q1 2020 | $155,000 | -37.2% | 15,837 | -26.1% | 0.00% | – |
Q4 2019 | $247,000 | +11.3% | 21,441 | -47.4% | 0.00% | – |
Q3 2019 | $222,000 | +276.3% | 40,731 | +303.0% | 0.00% | – |
Q1 2018 | $59,000 | -45.4% | 10,108 | -65.9% | 0.00% | – |
Q3 2017 | $108,000 | – | 29,668 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |